185 related articles for article (PubMed ID: 37646524)
1. Spontaneous mutational patterns and novel mutations for bedaquiline and clofazimine resistance in
Shi J; Liu Y; Wu T; Li L; Han S; Peng X; Shang Y; Guo Y; Pang Y; Gao M; Lu J
Microbiol Spectr; 2023 Aug; 11(5):e0009023. PubMed ID: 37646524
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of resistance and treatment efficacy of clofazimine and bedaquiline against
Islam MM; Alam MS; Liu Z; Khatun MS; Yusuf B; Hameed HMA; Tian X; Chhotaray C; Basnet R; Abraha H; Zhang X; Khan SA; Fang C; Li C; Hasan S; Tan S; Zhong N; Hu J; Zhang T
Front Med (Lausanne); 2023; 10():1304857. PubMed ID: 38274444
[TBL] [Abstract][Full Text] [Related]
3. Bedaquiline resistance pattern in clofazimine-resistant clinical isolates of tuberculosis patients.
Shang Y; Chen S; Shi W; Nie W; Jing W; Huo F; Xue Y; Dong L; Jiang G; Huang H; Chu N
J Glob Antimicrob Resist; 2023 Jun; 33():294-300. PubMed ID: 37142094
[TBL] [Abstract][Full Text] [Related]
4. Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678.
Snobre J; Villellas MC; Coeck N; Mulders W; Tzfadia O; de Jong BC; Andries K; Rigouts L
Sci Rep; 2023 Jun; 13(1):10444. PubMed ID: 37369740
[TBL] [Abstract][Full Text] [Related]
5. Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis.
Liu Y; Gao J; Du J; Shu W; Wang L; Wang Y; Xue Z; Li L; Xu S; Pang Y
Int J Infect Dis; 2021 Jan; 102():392-396. PubMed ID: 33130209
[TBL] [Abstract][Full Text] [Related]
6. Investigation of Clofazimine Resistance and Genetic Mutations in Drug-Resistant
Park S; Jung J; Kim J; Han SB; Ryoo S
J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407536
[TBL] [Abstract][Full Text] [Related]
7. Variants associated with Bedaquiline (BDQ) resistance identified in Rv0678 and efflux pump genes in Mycobacterium tuberculosis isolates from BDQ naïve TB patients in Pakistan.
Saeed DK; Shakoor S; Razzak SA; Hasan Z; Sabzwari SF; Azizullah Z; Kanji A; Nasir A; Shafiq S; Ghanchi NK; Hasan R
BMC Microbiol; 2022 Feb; 22(1):62. PubMed ID: 35209842
[TBL] [Abstract][Full Text] [Related]
8. Bedquiline Resistance Mutations: Correlations with Drug Exposures and Impact on the Proteome in M. tuberculosis.
Xu J; Li D; Shi J; Wang B; Ge F; Guo Z; Mu X; Nuermberger E; Lu Y
Antimicrob Agents Chemother; 2023 Jul; 67(7):e0153222. PubMed ID: 37255473
[TBL] [Abstract][Full Text] [Related]
9. Bedaquiline, Delamanid, Linezolid, Clofazimine, and Capreomycin MIC Distributions for Drug Resistance
Guo Y; Yang J; Wang W; Wu X; Wan B; Wang H; Sha W; Yu F
Infect Drug Resist; 2023; 16():7587-7595. PubMed ID: 38107433
[TBL] [Abstract][Full Text] [Related]
10. Genotype-Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis.
Brown TS; Tang L; Omar SV; Joseph L; Meintjes G; Maartens G; Wasserman S; Shah NS; Farhat MR; Gandhi NR; Ismail N; Brust JCM; Mathema B
Clin Infect Dis; 2024 Feb; 78(2):269-276. PubMed ID: 37874928
[TBL] [Abstract][Full Text] [Related]
11. Sub-MIC levels of bedaquiline and clofazimine can select
Villellas C; Stevenaert F; Remmerie B; Andries K
Antimicrob Agents Chemother; 2024 Apr; 68(4):e0127523. PubMed ID: 38470194
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of multidrug-resistant tuberculosis against levofloxacin, moxifloxacin, bedaquiline, linezolid, clofazimine, and delamanid in southwest of China.
Zheng H; He W; Jiao W; Xia H; Sun L; Wang S; Xiao J; Ou X; Zhao Y; Shen A
BMC Infect Dis; 2021 Apr; 21(1):330. PubMed ID: 33832459
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: A subsequent study of a national survey.
Wang G; Jiang G; Jing W; Zong Z; Yu X; Chen S; Li W; Huang H
J Infect; 2021 Mar; 82(3):371-377. PubMed ID: 33556430
[TBL] [Abstract][Full Text] [Related]
14. Defining Bedaquiline Susceptibility, Resistance, Cross-Resistance and Associated Genetic Determinants: A Retrospective Cohort Study.
Ismail NA; Omar SV; Joseph L; Govender N; Blows L; Ismail F; Koornhof H; Dreyer AW; Kaniga K; Ndjeka N
EBioMedicine; 2018 Feb; 28():136-142. PubMed ID: 29337135
[TBL] [Abstract][Full Text] [Related]
15.
Pang Y; Zong Z; Huo F; Jing W; Ma Y; Dong L; Li Y; Zhao L; Fu Y; Huang H
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739779
[TBL] [Abstract][Full Text] [Related]
16. Primary Bedaquiline Resistance Among Cases of Drug-Resistant Tuberculosis in Taiwan.
Wu SH; Chan HH; Hsiao HC; Jou R
Front Microbiol; 2021; 12():754249. PubMed ID: 34745058
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic interaction between bedaquiline and clofazimine in patients with drug-resistant tuberculosis.
Maartens G; Brill MJE; Pandie M; Svensson EM
Int J Tuberc Lung Dis; 2018 Jan; 22(1):26-29. PubMed ID: 29145924
[TBL] [Abstract][Full Text] [Related]
18.
Degiacomi G; Sammartino JC; Sinigiani V; Marra P; Urbani A; Pasca MR
Front Microbiol; 2020; 11():559469. PubMed ID: 33042066
[TBL] [Abstract][Full Text] [Related]
19.
Zhang L; Zhang Y; Li Y; Huo F; Chen X; Zhu H; Guo S; Fu L; Wang B; Lu Y
Microbiol Spectr; 2023 Aug; 11(5):e0000223. PubMed ID: 37615440
[TBL] [Abstract][Full Text] [Related]
20. Delamanid and bedaquiline resistance patterns in
Akbari Aghababa A; Nasiri MJ; Pakzad P; Mirsamadi ES
New Microbes New Infect; 2024; 60-61():101437. PubMed ID: 38873345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]